Yeah TLX592 seems OK in that respect though.
Early days but from their proof of concept study recently released;
Initial results demonstrate rapid elimination from blood circulation compared to standard antibodies and hepatic (liver) clearance – both highly desirable characteristics for use with alpha emitting agents.
Yeah TLX592 seems OK in that respect though.Early days but from...
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.51 |
Change
0.030(0.40%) |
Mkt cap ! $2.371B | |||
| Open | High | Low | Value | Volume |
| $7.47 | $7.55 | $7.44 | $6.874M | 917.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 256 | $7.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.52 | 23925 | 1 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |